Cover Image

Dupilumab as an innovative therapy for symptomatic management of chemotherapy‐induced pruritus: A case series

Saved in:

Bibliographic Details
Main Authors:	Nupur Singh (Author), Anna Conner (Author), Zachary Nahmias (Author)
Format:	Book
Published:	Wiley, 2024-04-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Dupilumab as a novel therapy for management of delusions of parasitosis: A case series
by: Nupur Singh, BA, et al.
Published: (2024)

Management of refractory pruritus in Alagille syndrome with dupilumab treatment: A case report
by: Daniel S. Alicea, MS, et al.
Published: (2024)

The use of dupilumab for the treatment of recalcitrant brachioradial pruritus
by: Mary Kathryn Abel, AB, et al.
Published: (2021)

Recalcitrant anal and genital pruritus treated with dupilumab
by: E.J. Yang, BS, et al.
Published: (2018)

Dupilumab Improves Pruritus in Netherton Syndrome: A Case Study
by: Yutaka Inaba, et al.
Published: (2022)

Incidental improvement of programmed cell death-1 receptor inhibitor-induced vitiligo after initiation of dupilumab therapy for refractory pruritus
by: Warner Robinson, DDS, et al.
Published: (2023)

Real‐world experience of using dupilumab and JAK inhibitors to manage pruritus in epidermolysis bullosa pruriginosa
by: Ping‐Chen Hou, et al.
Published: (2024)

Six cases of refractory pruritus and histologic dermal hypersensitivity reaction successfully treated with dupilumab
by: Nicole Edmonds, BA, et al.
Published: (2022)

Effectiveness of topical peppermint oil on symptomatic treatment of chronic pruritus
by: Elsaie LT, et al.
Published: (2016)

Refractory pruritus responds to dupilumab in a patient with TTC7A mutation
by: Yassaman Alipour Tehrany, MD, et al.
Published: (2021)

[Translated article] Successful Control of Recalcitrant Pruritus in Epidermolysis Bullosa Pruriginosa With Dupilumab
by: B. Roque Quintana, et al.
Published: (2024)

Upadacitinib as a treatment for chronic pruritus secondary to polycythemia vera after failure with dupilumab
by: Christopher I. Wachuku, MS, et al.
Published: (2023)

Rapid resolution of widespread cutaneous lichen planus and generalized pruritus in an elderly patient following treatment with dupilumab
by: Soroush Kazemi, BS, et al.
Published: (2022)

Baricitinib rapidly and sustainably relieves a patient from chronic pruritus of unknown origin refractory to dupilumab
by: Thomas Buttgereit, MD, et al.
Published: (2021)

Chronic Pruritus in Atopic Patients Treated with Dupilumab: Real Life Response and Related Parameters in 354 Patients
by: Luca Mastorino, et al.
Published: (2022)

Neuraxial opioid-induced pruritus: An update
by: Kamal Kumar, et al.
Published: (2013)

Tattoo pruritus successfully treated with ruxolitinib: A case series
by: Julianna Shin, BS, et al.
Published: (2024)

Chemotherapy-induced Spontaneous Pneumothorax: Case Series
by: Een Hendarsih, et al.
Published: (2016)

Dupilumab for Chronic Prurigo in Different Backgrounds: A Case Series
by: Luo N, et al.
Published: (2022)

Impact of drug therapy on brachioradial pruritus
by: Patrick Alexander Wachholz, et al.
Published: (2017)

Vitiligo during dupilumab therapy
by: Vincenzo Picone, MD, et al.
Published: (2023)

Oral gabapentin for scalp pruritus in patients with lichen planopilaris: A case series
by: Li-Chi Chen, MD, MPH, et al.
Published: (2024)

Eczematous reactions to psoriasis biologics treated with dupilumab: A case series
by: Merav Koschitzky, BA, et al.
Published: (2021)

Dupilumab in Treatment of Chronic Prurigo: A Case Series and Literature Review
by: Zaid Z. Almustafa, et al.
Published: (2019)

Dupilumab-induced pityriasis rosea
by: Morgan Zabel, BS, et al.
Published: (2023)

Dupilumab-induced erythema nodosum
by: Danielle E. Mustin, MEng, et al.
Published: (2022)

JAK-inhibitors as rescue therapy in dupilumab-refractory severe atopic dermatitis: A case series of 6 patients
by: Neda Shahriari, MD, et al.
Published: (2023)

Management of Pruritus in Chronic Liver Disease
by: Angeline Bhalerao, et al.
Published: (2015)

Pruritus. Pathomechanism, management and novel treatment
by: Maciej Józefiak, et al.
Published: (2023)

Long-term conservative management of symptomatic bladder endometriosis: A case series of 17 patients
by: Natsuki Nagashima, et al.
Published: (2022)

Individualized dupilumab therapy in the treatment of pediatric patients with severe atopic dermatitis: Case series in a Malaysian Tertiary Center
by: Wai Quen Lee, et al.
Published: (2022)

Dupilumab Significantly Reduces Symptoms of Prurigo Nodularis and Depression: A Case Series
by: Louise Lönndahl, et al.
Published: (2022)

Dupilumab in HIV-positive patients: A case series report of 4 patients
by: Ameen Alawadhi, MD, et al.
Published: (2020)

Severe pediatric asthma therapy: Dupilumab
by: Giuliana Ferrante, et al.
Published: (2022)

A pediatric case of dupilumab-induced pustular psoriasis
by: Nan Dang, et al.
Published: (2024)

Pustular Psoriasis Induced by Dupilumab: A Case Report
by: Liu Y, et al.
Published: (2024)

Chinese Guidelines for the Management of Chronic Pruritus (2018)
by: The Allergic Disease Committee of Chinese Dermatologist Association∗
Published: (2020)

Intravenous immunoglobulin-induced eczematous dermatitis treated with dupilumab
by: Katelyn Singh, MD, et al.
Published: (2024)

Recalcitrant Palmar-Plantar Atopic Dermatitis Successfully Treated with Dupilumab: A Case Series
by: Deng L, et al.
Published: (2022)

Dupilumab for patients with photoaggravated dermatoses with skin nodules as main manifestations: A case series
by: Ruixian Ye, et al.
Published: (2023)